Director, Laboratory of SCI, Stem Cell & Recovery Neurobiology Research
Harvard Medical School,Spaulding Rehabilitation Hospital,Brigham & Women's Hosp
Boston, Massachusetts
Biosketch
Dr. Teng earned his Ph.D. in Cell Biology/Neuroscience at Georgetown University, Washington D.C., investigating secondary injury mechanisms and therapeutic interventions of spinal cord injury (SCI). For postdoctoral training, he studied respiratory neurobiology, and stem cell biology and neurodegeneration at Georgetown University, and Boston Children’s Hospital and Harvard Medical School, respectively. He is Director of the Laboratory of SCI, Stem Cell & Recovery Neurobiology Research and Co-Director of Neurotrauma Recovery Research, Department of Physical Medicine & Rehabilitation (PM&R), Harvard Medical School, Spaulding Rehabilitation Hospital Network, and Mass General Brigham. His primary academic interest concerns theoretical frameworks of spinal cord neurobiology. Dr. Teng and his team investigate recovery neurobiology of injured spinal cords and functional multipotency of stem cells through multimodal approaches that integrate research strategies of stem cell biology, chemical engineering, glial biology, neural oncology, and molecular pharmacology.
He and his collaborators have received the David S. Apple Award of the American Spinal Injury Association (ASIA; 2011), the ERF New Investigator Award from the Foundation of Physical Medicine & Rehabilitation (2004), the Annual CNS Research Award from the Congress of Neurological Surgeons (2001), and the Mayfield Award (2012) and Larson Award (2015 and 2016) from the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS) Joint Section on Disorders of the Spine and Peripheral Nerves. Dr. Teng was recently recognized with the Distinguished Research Mentor Award (2019) presented by Spaulding Rehabilitation Hospital Network and Department of PM&R, Harvard Medical Scholl, and Australia-Harvard Fellowship (2020-2022) from the Harvard Club of Australia Foundation.
Disclosure information not submitted.
Thursday, April 21, 2022
1:00 PM – 2:00 PM US CST